与代谢功能障碍相关的脂肪性肝病
Catherine Hsu1, William Alazawi1
1Queen Mary University of London.
与代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为NAFLD,影响英国的三分之一. 一般医生的早期诊断和风险分层对于管理肝纤维化和相关心脏代谢疾病至关重要.
科学领域:
- 肝病学和胃肠病学 肝病学和胃肠学
- 公共卫生和流行病学
- 心脏代谢医学心脏代谢医学
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD),以前称为非酒精性脂肪性肝病 (NAFLD),是一个日益严重的公共卫生问题.
- 肝肥胖症影响英国大约三分之一的人口,经常与2型糖尿病和缺血性心脏病一起发生.
- MASLD诊断通常发生在初级保健中,通过异常的肝功能测试或偶然的超声检测结果.
研究的目的:
- 强调初级保健医生在诊断MASLD时的重要性.
- 强调需要对MASLD患者的风险分层,特别是肝纤维化.
- 引导适当的患者管理和转诊途径.
主要方法:
- 对社区中MASLD的当前诊断方法的审查.
- 评估英国MASLD的患病率和并发症.
- 在MASLD中讨论肝纤维化风险分层工具.
主要成果:
- MASLD的流行程度很高,影响了英国人口的很大一部分.
- MASLD经常与其他严重的心脏代谢疾病共存.
- 初级保健医生在最初的MASLD识别中发挥着关键作用.
结论:
- 一般医生必须具备诊断和风险分层MASLD的设备.
- 对有纤维化风险的患者来说,有效的治疗和及时转诊肝病学是必不可少的.
- 解决MASLD对于管理相关心脏代谢疾病和改善公共卫生结果至关重要.
更多相关视频
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
相关概念视频
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Inborn Errors of Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
